Japan-based Otsuka Pharmaceutical Company announced the approval of their medication system. The pill with a built-in digital tracking device will be used in a psychiatric setting to help treat schizophrenia, a psychotic disorder, which includes symptoms of delusions and hallucinations. To read more about this digital drug, click here.